1-10 of 10
Stefano Perlini
Close
Sort by
Journal Articles

Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies

Clinical Trials & Observations
Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini, Giampaolo Merlini
Journal: Blood
Blood (2018) 131 (5): 525–532.
https://doi.org/10.1182/blood-2017-04-780544
Published: 2018
Includes: Supplemental data
Journal Articles

Proteotoxicity in Cardiac Amyloidosis: Amyloidogenic Light Chains Affect the Levels of Iintracellular Proteins in Human Heart Cells

Esther Imperlini, PhD, Massimiliano Gnecchi, MD PhD, Paola Rognoni, PhD, Eduard Sabidò, PhD, Maria Chiara Ciuffreda, Giovanni Palladini, MDPhD, Guadalupe Espadas, Giuseppina Palladini, Stefania Orrù, PhD, Paolo Milani, MD PhD, Stefano Perlini, MD PhD, Francesco Salvatore, MD PhD, Giampaolo Merlini, MD, Francesca Lavatelli, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4393.
https://doi.org/10.1182/blood.V130.Suppl_1.4393.4393
Published: 2017
Journal Articles

A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis

Clinical Trials & Observations Brief Report
Giovanni Palladini, Paolo Milani, Andrea Foli, Marco Basset, Francesca Russo, Stefano Perlini, Giampaolo Merlini
Journal: Blood
Blood (2017) 129 (15): 2120–2123.
https://doi.org/10.1182/blood-2016-12-756528
Published: 2017
Includes: Supplemental data
Journal Articles

The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44

Vittorio Perfetti, Giovanni Palladini, Simona Casarini, Valentina Navazza, Paola Rognoni, Laura Obici, Rosangela Invernizzi, Stefano Perlini, Catherine Klersy, Giampaolo Merlini
Journal: Blood
Blood (2012) 119 (1): 144–150.
https://doi.org/10.1182/blood-2011-05-355784
Published: 2012
Journal Articles

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

Clinical Trials & Observations
Giovanni Palladini, Alessandra Barassi, Catherine Klersy, Rosana Pacciolla, Paolo Milani, Gabriele Sarais, Stefano Perlini, Riccardo Albertini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Laura Obici, Remigio Moratti, Gian Vico Melzi d'Eril, Giampaolo Merlini
Journal: Blood
Blood (2010) 116 (18): 3426–3430.
https://doi.org/10.1182/blood-2010-05-286567
Published: 2010
Includes: Supplemental data
Journal Articles

High-Sensitivity Troponin Assay Improves the Detection of Cardiac Involvement in AL Amyloidosis and Is the Most Powerful Prognostic Determinant.

Giovanni Palladini, Alessandra Barassi, Gabriele Sarais, Ruggero Capra, Andrea Foli, Paola Russo, Riccardo Albertini, Letizia Zenone Bragotti, Laura Obici, Stefano Perlini, Remigio Moratti, Gian Vico Melzi D'Eril, Giampaolo Merlini
Journal: Blood
Blood (2009) 114 (22): 1782.
https://doi.org/10.1182/blood.V114.22.1782.1782
Published: 2009
Journal Articles

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Letizia Zenone Bragotti, Andrea Foli, Francesco Musca, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini
Journal: Blood
Blood (2009) 114 (22): 2863.
https://doi.org/10.1182/blood.V114.22.2863.2863
Published: 2009
Journal Articles

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini
Journal: Blood
Blood (2009) 114 (22): 3889.
https://doi.org/10.1182/blood.V114.22.3889.3889
Published: 2009
Journal Articles

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL

Clinical Trials & Observations
Giovanni Palladini, Francesca Lavatelli, Paola Russo, Stefano Perlini, Vittorio Perfetti, Tiziana Bosoni, Laura Obici, Arthur R. Bradwell, GianVico Melzi D'Eril, Roberto Fogari, Remigio Moratti, Giampaolo Merlini
Journal: Blood
Blood (2006) 107 (10): 3854–3858.
https://doi.org/10.1182/blood-2005-11-4385
Published: 2006
Journal Articles

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)

Clinical Trials & Observations Brief Report
Giovanni Palladini, Vittorio Perfetti, Stefano Perlini, Laura Obici, Francesca Lavatelli, Riccardo Caccialanza, Rosangela Invernizzi, Benedetto Comotti, Giampaolo Merlini
Journal: Blood
Blood (2005) 105 (7): 2949–2951.
https://doi.org/10.1182/blood-2004-08-3231
Published: 2005